United States · FDA National Drug Code directory

Cefoxitin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
25021-111_79813968-4f6f-49a9-9a94-18607a1bcfbf
Product NDC
25021-111
Form
INJECTION, POWDER, FOR SOLUTION
Composition / generic term
cefoxitin
Labeler
Sagent Pharmaceuticals
Marketing category
ANDA
Marketing start / end (source format)
20100812
Source listing expiry
20261231

Source-listed ingredients

  • CEFOXITIN SODIUM — 10 g/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 BOTTLE in 1 CARTON (25021-111-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLE · 25021-111-99

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Cefoxitin — United States | Molindra Medicines